During October 2005 we created Lifestyle Choices, Our new first spin-out company from the University of Sheffield pipeline agreement. Lifestyle Choices will offer a range of products in the female fertility and menopause markets and launched its first product, a new triple hormone ovarian reserve test called Plan Ahead, in January 2006.

Lifestyle Choices believes this test offers the most accurate hormone based ovarian reserve test available to the public, enabling women to make more informed decisions about whether to try for a baby sooner rather than later.

Developed by Professor Bill Ledger, Professor of Obstetrics and Gynaecology at the University of Sheffield, Plan Ahead measures three hormone levels in the blood. The first two are the ovarian hormones, Inhibin B and AMH; and the third is FSH, a pituitary hormone. The result is a predictive assessment of the number of eggs in the woman’s ovaries compared to levels expected for women of the same age. The test is accurate for up to two years ahead.